Publication:
Ubiquitin stimulated reversal of topoisomerase 2 DNA-protein crosslinks by TDP2.

dc.contributor.authorSchellenberg, Matthew J
dc.contributor.authorAppel, C Denise
dc.contributor.authorRiccio, Amanda A
dc.contributor.authorButler, Logan R
dc.contributor.authorKrahn, Juno M
dc.contributor.authorLiebermann, Jenna A
dc.contributor.authorCortés-Ledesma, Felipe
dc.contributor.authorWilliams, R Scott
dc.date.accessioned2023-02-08T14:48:11Z
dc.date.available2023-02-08T14:48:11Z
dc.date.issued2020
dc.description.abstractTyrosyl-DNA phosphodiesterase 2 (TDP2) reverses Topoisomerase 2 DNA-protein crosslinks (TOP2-DPCs) in a direct-reversal pathway licensed by ZATTZNF451 SUMO2 E3 ligase and SUMOylation of TOP2. TDP2 also binds ubiquitin (Ub), but how Ub regulates TDP2 functions is unknown. Here, we show that TDP2 co-purifies with K63 and K27 poly-Ubiquitinated cellular proteins independently of, and separately from SUMOylated TOP2 complexes. Poly-ubiquitin chains of ≥ Ub3 stimulate TDP2 catalytic activity in nuclear extracts and enhance TDP2 binding of DNA-protein crosslinks in vitro. X-ray crystal structures and small-angle X-ray scattering analysis of TDP2-Ub complexes reveal that the TDP2 UBA domain binds K63-Ub3 in a 1:1 stoichiometric complex that relieves a UBA-regulated autoinhibitory state of TDP2. Our data indicates that that poly-Ub regulates TDP2-catalyzed TOP2-DPC removal, and TDP2 single nucleotide polymorphisms can disrupt the TDP2-Ubiquitin interface.
dc.identifier.doi10.1093/nar/gkaa318
dc.identifier.essn1362-4962
dc.identifier.pmcPMC7293035
dc.identifier.pmid32356875
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293035/pdf
dc.identifier.unpaywallURLhttps://academic.oup.com/nar/article-pdf/48/11/6310/33384731/gkaa318.pdf
dc.identifier.urihttp://hdl.handle.net/10668/15476
dc.issue.number11
dc.journal.titleNucleic acids research
dc.journal.titleabbreviationNucleic Acids Res
dc.language.isoen
dc.organizationCentro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER
dc.page.number6310-6325
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, N.I.H., Extramural
dc.pubmedtypeResearch Support, N.I.H., Intramural
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.pubmedtypeResearch Support, U.S. Gov't, Non-P.H.S.
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subject.meshBinding Sites
dc.subject.meshCatalytic Domain
dc.subject.meshCrystallography, X-Ray
dc.subject.meshDNA
dc.subject.meshDNA Topoisomerases, Type II
dc.subject.meshDNA-Binding Proteins
dc.subject.meshHumans
dc.subject.meshModels, Molecular
dc.subject.meshMutation
dc.subject.meshPhosphoric Diester Hydrolases
dc.subject.meshPolyubiquitin
dc.subject.meshProtein Binding
dc.subject.meshSmall Ubiquitin-Related Modifier Proteins
dc.subject.meshSubstrate Specificity
dc.subject.meshSumoylation
dc.subject.meshUbiquitin
dc.titleUbiquitin stimulated reversal of topoisomerase 2 DNA-protein crosslinks by TDP2.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number48
dspace.entity.typePublication

Files